Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Markers of Chemoresistance in Metastatic Colorectal Cancer
NCT00559676Phase 4Completed
- Sponsor
- CHU de Limoges
- Start
- Mar 2005
- Primary completion
- May 2011
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fluorouracil, capecitabine, irinotecan, oxaliplatin in colorectal cancer (CRC), sponsored by CHU de Limoges. Started Mar 2005; status: completed.
02
Drugs
fluorouracilcapecitabineirinotecanoxaliplatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00559676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00559676.